An Investigators Brochure (IB) is a document used in clinical trials that provides a summary of the drug or product being tested. The purpose of the IB is to provide information to investigators and sponsors about the drug or product being studied so they can make informed decisions about its use in clinical trials. The IB typically contains the following information:
- Description of the drug or product: The IB provides a description of the drug or product being studied, including its chemical and physical properties, its pharmacology, and its mechanism of action.
- Preclinical studies: The IB includes a summary of the preclinical studies that have been conducted on the drug or product, including animal studies and in vitro studies.
- Clinical studies: The IB also provides information on any previous clinical studies that have been conducted on the drug or product, including information on the study design, patient population, dosing, and adverse events.
- Safety data: The IB contains a summary of the safety data that has been collected on the drug or product, including any adverse events, drug interactions, or contraindications.
- Manufacturing information: The IB includes information on the manufacturing process for the drug or product, including the composition, stability, and storage requirements.
- Regulatory status: The IB provides information on the regulatory status of the drug or product, including any approvals or rejections from regulatory agencies.
The IB is a critical document in the conduct of clinical trials and is updated as new information becomes available during the course of the trial. It is used by investigators, sponsors, and regulatory agencies to ensure that the drug or product being studied is safe and effective for use in clinical trials.
You may be interested in the programs below: